| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3331381
Max Phase: Preclinical
Molecular Formula: C27H25N4O8P
Molecular Weight: 564.49
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccc2cc(-c3cccc(-c4ncnc5c4ncn5[C@@H]4O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]4O)c3)ccc2c1
Standard InChI: InChI=1S/C27H25N4O8P/c1-37-20-8-7-17-9-16(5-6-18(17)11-20)15-3-2-4-19(10-15)22-23-26(29-13-28-22)31(14-30-23)27-25(33)24(32)21(39-27)12-38-40(34,35)36/h2-11,13-14,21,24-25,27,32-33H,12H2,1H3,(H2,34,35,36)/t21-,24-,25-,27-/m1/s1
Standard InChI Key: HHJQAMYPGXZTHK-VBCUVWSKSA-N
Associated Targets(Human)
DNPH1 Tchem 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
Associated Targets(non-human)
Dnph1 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 564.49 | Molecular Weight (Monoisotopic): 564.1410 | AlogP: 3.05 | #Rotatable Bonds: 7 |
| Polar Surface Area: 169.28 | Molecular Species: ACID | HBA: 10 | HBD: 4 |
| #RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 1.22 | CX Basic pKa: 2.96 | CX LogP: 1.43 | CX LogD: -1.00 |
| Aromatic Rings: 5 | Heavy Atoms: 40 | QED Weighted: 0.21 | Np Likeness Score: 0.48 |
References
| 1. Amiable C, Paoletti J, Haouz A, Padilla A, Labesse G, Kaminski PA, Pochet S.. (2014) 6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities., 85 [PMID:25108359] [10.1016/j.ejmech.2014.07.110] |
Source
Source(1):